ArticleAntibiotics (Basel, Switzerland)2021
Antimicrobial Resistance Genes and Diversity of Clones among ESBL- and Acquired AmpC-Producing
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 21 citations in OpenAlex.
- Extended-Spectrum β-Lactamase-ProducingAnimals : an open access journal from MDPI · 2026Article
- Serogrouping and Molecular Characterization of ESBL-Producing Avian PathogenicAntibiotics (Basel, Switzerland) · 2025Article
- Genomic analysis of the first multidrug-resistant ESBL-producing high-risk clonal lineage Klebsiella pneumoniae ST147 isolated from a cat with urinary tract infection.Veterinary research communications · 2024Article
- Antimicrobial resistance in food-associatedBioscience of microbiota, food and health · 2024Review
- Domestic cats are potential reservoirs of multidrug-resistant human enteropathogenicSaudi journal of biological sciences · 2023Article
- Fecal Carriage of Extended-Spectrum β-Lactamase-/AmpC-ProducingAntibiotics (Basel, Switzerland) · 2023Article
- Detection of Antibiotic Resistance in Feline-Origin ESBLInternational journal of molecular sciences · 2023Article
- ESBL- and Carbapenemase-ProducingMicroorganisms · 2023Article
- Antibiotic Susceptibility Profiles and Resistance Mechanisms to β-Lactams and Polymyxins ofMicroorganisms · 2022Article
- Urban Pigeons (Antibiotics (Basel, Switzerland) · 2022Article
- CTX-M-Producing Bacteria Isolated from a Highly Polluted River System in Portugal.International journal of environmental research and public health · 2022Article
- Multiple and High-Risk Clones of Extended-Spectrum Cephalosporin-Resistant andAntibiotics (Basel, Switzerland) · 2021Article
- Prevalence and Characterization of ESBL/AmpC ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Characterization of ESBL-ProducingMicroorganisms · 2021Article
- Antimicrobial Resistance Genes and Diversity of Clones among Faecal ESBL-ProducingAntibiotics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 3 countries.
Funding
Abstract
The aim of the study was to analyze the mechanisms of resistance in extended-spectrum beta-lactamase (ESBL)- and acquired AmpC (qAmpC)-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.